Alphabet is an internet content & information business based in the US. Alphabet stocks (GOOGL.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2568.4299 – an increase of 1.56% over the previous week. Alphabet employs 139,995 staff and has a trailing 12-month revenue of around $196.7 billion.
Since the stock market crash in March caused by coronavirus, Alphabet's stock price has had significant positive movement.
Its last market close was $2393.5701, which is 38.02% up on its pre-crash value of $1483.46 and 137.25% up on the lowest point reached during the March crash when the stocks fell as low as $1008.87.
If you had bought $1,000 worth of Alphabet stocks at the start of February 2020, those stocks would have been worth $706.27 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,603.69.
|Latest market close||$2393.5701|
|52-week range||$1402.15 - $2586.53|
|50-day moving average||$2462.7144|
|200-day moving average||$2194.8125|
|Wall St. target price||$2764.46|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$75.04|
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 month (2021-06-25)||-2.31%|
|3 months (2021-04-26)||3.62%|
Valuing Alphabet stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alphabet's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Alphabet's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 34x. In other words, Alphabet stocks trade at around 34x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stocks or simply that they're over-valued.
Alphabet's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4515. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Alphabet's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Alphabet's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$63 billion.
The EBITDA is a measure of a Alphabet's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$196.7 billion|
|Operating margin TTM||25.26%|
|Gross profit TTM||USD$97.8 billion|
|Return on assets TTM||10.34%|
|Return on equity TTM||23.69%|
|Market capitalisation||USD$1.8 trillion|
TTM: trailing 12 months
There are currently 2.8 million Alphabet stocks held short by investors – that's known as Alphabet's "short interest". This figure is 2.1% up from 2.7 million last month.
There are a few different ways that this level of interest in shorting Alphabet stocks can be evaluated.
Alphabet's "short interest ratio" (SIR) is the quantity of Alphabet stocks currently shorted divided by the average quantity of Alphabet stocks traded daily (recently around 1.2 million). Alphabet's SIR currently stands at 2.23. In other words for every 100,000 Alphabet stocks traded daily on the market, roughly 2230 stocks are currently held short.
However Alphabet's short interest can also be evaluated against the total number of Alphabet stocks, or, against the total number of tradable Alphabet stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Alphabet's short interest could be expressed as 0% of the outstanding stocks (for every 100,000 Alphabet stocks in existence, roughly 0 stocks are currently held short) or 0.0047% of the tradable stocks (for every 100,000 tradable Alphabet stocks, roughly 5 stocks are currently held short).
Such a low SIR usually points to an optimistic outlook for the stock price, with fewer people currently willing to bet against Alphabet.
Find out more about how you can short Alphabet stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Alphabet.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 20.35
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Alphabet's overall score of 20.35 (as at 12/31/2018) is pretty good – landing it in it in the 29th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Alphabet is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.52/100
Social score: 6.37/100
Governance score: 7.99/100
Controversy score: 4/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Alphabet scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that Alphabet has a damaged public profile.
|Total ESG score||20.35|
|Total ESG percentile||29.34|
|Level of controversy||4|
We're not expecting Alphabet to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.
Alphabet stocks were split on a 1998:1000 basis on 2 April 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1998 shares. This wouldn't directly have changed the overall worth of your Alphabet stocks – just the quantity. However, indirectly, the new 49.9% lower stock price could have impacted the market appetite for Alphabet stocks which in turn could have impacted Alphabet's stock price.
Over the last 12 months, Alphabet's stocks have ranged in value from as little as $1402.15 up to $2586.53. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alphabet's is 1.0109. This would suggest that Alphabet's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Alphabet Inc. provides online advertising services in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. The company offers performance and brand advertising services. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, such as ads, Android, Chrome, hardware, Google Maps, Google Play, Search, and YouTube, as well as technical infrastructure; and digital content. The Google Cloud segment offers infrastructure and data analytics platforms, collaboration tools, and other services for enterprise customers. The Other Bets segment sells internet and TV services, as well as licensing and research and development services. The company was founded in 1998 and is headquartered in Mountain View, California.
Everything we know about the Ryan Specialty Group Holdings IPO, plus information on how to buy in.
Everything we know about the Ocean Biomedical IPO, plus information on how to buy in.
Everything we know about the Instructure Holdings IPO, plus information on how to buy in.
Everything we know about the Gambling.com Group IPO, plus information on how to buy in.
Everything we know about the Elicio Therapeutics IPO, plus information on how to buy in.
Everything we know about the Cytek Biosciences IPO, plus information on how to buy in.
Everything we know about the Core & Main IPO, plus information on how to buy in.
Everything we know about the Caribou Bioscience IPO, plus information on how to buy in.
Everything we know about the Candel Therapeutics IPO, plus information on how to buy in.
Everything we know about the Absci Corporation IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.